CSL Behring is a member of the CSL Group of companies. Parent company CSL Limited is a specialty biopharmaceutical company headquartered in Parkville, Australia. CSL Behring and CSL Limited, continue to build on a long legacy of innovation in patient care. CSL Behring traces beginnings to the 1904 founding of Behringwerke, a company established by the first winner of the Nobel Prize in Medicine, Emil von Behring.
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products. Its line of therapies includes products for the treatment of bleeding disorders such as hemophilia and von Willebrand Disease; primary immune deficiencies (PIDD); hereditary angioedema; inherited respiratory disease; and neurological disorders in certain markets. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic diseases in the newborn.